Charles River CEO says it likely won’t be the last manufacturer to break away from cell and gene therapy

Birgit Girshick, Charles River CEO (Credit: Charles River) May 28, 2026 09:38 AM EDTUpdated May 29, 06:14 AM PharmaCell/Gene TxManufacturing Charles Riv­er CEO says it like­ly won’t be the last man­u­fac­tur­er to break away from cell and gene ther­a­py Anna Brown News Reporter Three months ago, Charles Riv­er Lab­o­ra­to­ries an­nounced it would shed its man­u­fac­tur­ing unit, which has a fo­cus on cell and gene ther­a­pies. And, ac­cord­ing to … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER